Company Filing History:
2 out of 2 
2 out of 32 
2 out of 2 Years Active: 2009-2011
Title: The Innovative Journey of Marie Ranson in Cancer Treatment
Introduction
Marie Ranson, a distinguished inventor based in Austinmer, Australia, has significantly contributed to the field of cancer research and treatment. With two patents to her name, she has dedicated her career to developing groundbreaking methods for detecting and treating cancerous cells.
Latest Patents
Ranson's latest patents focus on the application of PAI-2 conjugates in the realm of cancer therapy. These innovations describe a method for detecting, visualizing, and treating cells that express the uPA/uPAR complex. The PAI-2 conjugate molecule is a pivotal element in this method, as it comprises PAI-2 or its functional derivatives, which are linked to a toxin or label for effective targeting and imaging of cancer cells.
Career Highlights
Throughout her career, Marie Ranson has made significant strides in her research, leading to the creation of her patented methods. She has worked with prominent organizations, including Pai-2 Pty Limited and the University of Wollongong, where she has made noteworthy contributions to medical research and innovation.
Collaborations
Ranson has collaborated with notable professionals in her field, such as Barry John Allen and Clive Leighton Bunn. These partnerships have enhanced her research capabilities and fostered a collaborative approach to solving complex problems in cancer treatment.
Conclusion
Marie Ranson is a remarkable inventor whose work on PAI-2 conjugates stands at the forefront of cancer detection and treatment. Her dedication to innovation and collaboration in the scientific community highlights her commitment to advancing medical science for the benefit of patients worldwide.